Tempus AI, Inc. (NASDAQ:TEM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 22, 2025, that ...
TheFly reported on December 22, 2025, that Canaccord reduced the price objective for Tempus AI, Inc. (NASDAQ:TEM) to $80 from $95. The shares were still rated as a buy by analyst Kyle Mikson. As noted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback